Skip to content 
National Research Corporation provides analytics and insights that facilitate measurement and improvement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company also offers marketing experience solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools through a multi-mode digital platform. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; employee experience solutions that give care teams information, tools and support needed to create engagement and open communication throughout the employee lifecycle; and consumer experience solutions which capture feedback across the healthcare journey, drive choice to build volume, and co-design experiences and services through community insights. Additionally, the company offers Huey AI, an AI engine for Human Understanding that serves as a healthcare experience management companion; and governance solutions for not-for-profit health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska. more
| Time Frame | NRC | Sector | S&P500 |
|---|---|---|---|
| 1-Week Return | -2.96% | 1.07% | 0.74% |
| 1-Month Return | -43.12% | 1.46% | 1.28% |
| 3-Month Return | -23.67% | 3.51% | 3.6% |
| 6-Month Return | -23.01% | 15.29% | 7.31% |
| 1-Year Return | -26.89% | 7.7% | 11.97% |
| 3-Year Return | -73.32% | 21.02% | 72.07% |
| 5-Year Return | -74.76% | 37.81% | 76.01% |
| 10-Year Return | -13.84% | 139.15% | 258.47% |
| Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | 5YR TREND | |
|---|---|---|---|---|---|---|
| Total Revenue | 147.95M | 151.57M | 148.58M | 143.06M | 137.39M | [{"date":"2021-12-31","value":97.62,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.03,"profit":true},{"date":"2024-12-31","value":94.39,"profit":true},{"date":"2025-12-31","value":90.65,"profit":true}] |
| Cost of Revenue | 52.35M | 57.05M | 56.02M | 56.93M | 59.99M | [{"date":"2021-12-31","value":87.26,"profit":true},{"date":"2022-12-31","value":95.09,"profit":true},{"date":"2023-12-31","value":93.37,"profit":true},{"date":"2024-12-31","value":94.9,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Gross Profit | 95.60M | 94.52M | 92.56M | 86.13M | 77.39M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.87,"profit":true},{"date":"2023-12-31","value":96.82,"profit":true},{"date":"2024-12-31","value":90.09,"profit":true},{"date":"2025-12-31","value":80.95,"profit":true}] |
| Gross Margin | 64.62% | 62.36% | 62.30% | 60.20% | 56.33% | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.51,"profit":true},{"date":"2023-12-31","value":96.41,"profit":true},{"date":"2024-12-31","value":93.17,"profit":true},{"date":"2025-12-31","value":87.18,"profit":true}] |
| Operating Expenses | 45.33M | 47.98M | 52.52M | 50.93M | 54.80M | [{"date":"2021-12-31","value":82.72,"profit":true},{"date":"2022-12-31","value":87.54,"profit":true},{"date":"2023-12-31","value":95.83,"profit":true},{"date":"2024-12-31","value":92.93,"profit":true},{"date":"2025-12-31","value":100,"profit":true}] |
| Operating Income | 50.27M | 46.54M | 40.05M | 35.19M | 22.59M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":92.59,"profit":true},{"date":"2023-12-31","value":79.66,"profit":true},{"date":"2024-12-31","value":70.01,"profit":true},{"date":"2025-12-31","value":44.94,"profit":true}] |
| Total Non-Operating Income/Expense | (3.30M) | (4.77M) | (50.00K) | (4.97M) | - | [{"date":"2021-12-31","value":-330200000,"profit":false},{"date":"2022-12-31","value":-476900000,"profit":false},{"date":"2023-12-31","value":-5000000,"profit":false},{"date":"2024-12-31","value":-497400000,"profit":false},{"date":"2025-12-31","value":"-","profit":true}] |
| Pre-Tax Income | 48.62M | 42.81M | 39.96M | 32.69M | 17.84M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.06,"profit":true},{"date":"2023-12-31","value":82.19,"profit":true},{"date":"2024-12-31","value":67.23,"profit":true},{"date":"2025-12-31","value":36.7,"profit":true}] |
| Income Taxes | 11.15M | 11.02M | 8.99M | 7.91M | 6.24M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.74,"profit":true},{"date":"2023-12-31","value":80.6,"profit":true},{"date":"2024-12-31","value":70.88,"profit":true},{"date":"2025-12-31","value":55.97,"profit":true}] |
| Income After Taxes | 37.47M | 31.80M | 30.97M | 24.78M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.88,"profit":true},{"date":"2023-12-31","value":82.66,"profit":true},{"date":"2024-12-31","value":66.15,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Continuous Operations | 37.47M | 31.80M | 28.75M | 24.78M | - | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.88,"profit":true},{"date":"2023-12-31","value":76.75,"profit":true},{"date":"2024-12-31","value":66.15,"profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Income From Discontinued Operations | - | - | - | - | - | [{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true},{"date":"2025-12-31","value":"-","profit":true}] |
| Net Income | 37.47M | 31.80M | 30.97M | 24.78M | 11.60M | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.88,"profit":true},{"date":"2023-12-31","value":82.66,"profit":true},{"date":"2024-12-31","value":66.15,"profit":true},{"date":"2025-12-31","value":30.96,"profit":true}] |
| EPS (Diluted) | 1.47 | 1.27 | 1.25 | 1.04 | 0.50 | [{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":86.39,"profit":true},{"date":"2023-12-31","value":85.03,"profit":true},{"date":"2024-12-31","value":71.01,"profit":true},{"date":"2025-12-31","value":34.34,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
| NRC | |
|---|---|
| Cash Ratio | 0.11 |
| Current Ratio | 0.55 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
| NRC | |
|---|---|
| ROA (LTM) | 10.56% |
| ROE (LTM) | 51.24% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
| NRC | |
|---|---|
| Debt Ratio Lower is generally better. Negative is bad. | 0.90 |
| Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.10 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
| NRC | |
|---|---|
| Trailing PE | 24.66 |
| Forward PE | NM |
| P/S (TTM) | 2.03 |
| P/B | 19.58 |
| Price/FCF | 46 |
| EV/R | 2.54 |
| EV/Ebitda | 11.54 |
National Research Corp (NRC) share price today is $12.45
Yes, Indians can buy shares of National Research Corp (NRC) on Vested. To buy
Yes, you can purchase fractional shares of National Research Corp (NRC) via the Vested app. You can start investing in National Research Corp (NRC) with a minimum investment of $1.
You can invest in shares of National Research Corp (NRC) via Vested in three simple steps:
The 52-week high price of National Research Corp (NRC) is $22.79. The 52-week low price of National Research Corp (NRC) is $9.52.
The price-to-earnings (P/E) ratio of National Research Corp (NRC) is 24.66
The price-to-book (P/B) ratio of National Research Corp (NRC) is 19.58
The dividend yield of National Research Corp (NRC) is 4.3%
The market capitalization of National Research Corp (NRC) is $279.12M
The stock symbol (or ticker) of National Research Corp is NRC
Consider the share price of National Research Corp as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether National Research Corp has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.
When investing in National Research Corp shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the National Research Corp stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.
Rather than merely checking the share price of National Research Corp and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that National Research Corp stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.
Link copied 
